Patents by Inventor Su-Jung Kim

Su-Jung Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE LIQUID FORMULA
    Publication number: 20240358827
    Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.
    Type: Application
    Filed: April 17, 2024
    Publication date: October 31, 2024
    Applicant: CELLTRION INC.
    Inventors: Joon Won LEE, Yeon Kyeong SHIN, Hye Young KANG, Kwang Woo KIM, So Young KIM, Su Jung KIM, Jun Seok OH, Won Yong HAN
  • Stable liquid pharmaceutical formulation of anti-influenza virus antibody
    Patent number: 12065482
    Abstract: A stable liquid pharmaceutical preparation of an anti-influenza virus antibody and, more specifically, a stable liquid pharmaceutical preparation that comprises: (A) an anti-influenza virus antibody or a mixture of two or more different types of anti-influenza virus antibodies; (B) a surfactant; (C) a sugar or a sugar derivative; and (D) an amino acid. The stable liquid pharmaceutical preparation for an anti-influenza virus antibody disclosed herein has excellent storage stability at low temperature (5° C.), room temperature (25° C.), and high temperature (40° C.) and excellent long-term (12 months) storage stability, and may be administered intravenously, intramuscularly, transdermally, subcutaneously, intraperitoneally, topically, or in combinations thereof.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: August 20, 2024
    Assignee: Celltrion Inc.
    Inventors: Joon Won Lee, Won Yong Han, Su Jung Kim, Jun Seok Oh, So Young Kim, Kwang Woo Kim, Yeon Kyeong Shin
  • STABLE LIQUID PHARMACEUTICAL PREPARATION
    Publication number: 20240269071
    Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.
    Type: Application
    Filed: March 1, 2024
    Publication date: August 15, 2024
    Inventors: Joon Won Lee, Won Yong Han, Su Jung Kim, Jun Seok Oh, So Young Kim, Su Hyeon Hong, Yeon Kyeong Shin
  • STABLE LIQUID PHARMACEUTICAL PREPARATION
    Publication number: 20240269069
    Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.
    Type: Application
    Filed: February 6, 2024
    Publication date: August 15, 2024
    Inventors: Joon Won Lee, Won Yong Han, Su Jung Kim, Jun Seok Oh, So Young Kim, Su Hyeon Hong, Yeon Kyeong Shin
  • DISPLAY DEVICE AND MANUFACTURING METHOD OF THE SAME
    Publication number: 20240196674
    Abstract: A display device and a manufacturing method of the same are provided. The display device comprises a substrate, a lower metal layer disposed on the substrate, and a gate metal layer disposed on the lower metal layer, wherein the gate metal layer includes a first portion covering the lower metal layer in a plan view, and a second portion protruding in a first direction from the lower metal layer in a plan view, and the lower metal layer includes a concavo-convex pattern disposed at a portion overlapping the second portion of the gate metal layer.
    Type: Application
    Filed: June 30, 2023
    Publication date: June 13, 2024
    Inventors: Do Gi LIM, Sung Mo KANG, Dong Seong KOO, Su Jung KIM, Ji Young BANG, Ji Hea LIM
  • Stable liquid formula comprising anti-TNFa antibody, acetate buffer, and glycine
    Patent number: 11986523
    Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: May 21, 2024
    Assignee: CELLTRION INC.
    Inventors: Joon Won Lee, Yeon Kyeong Shin, Hye Young Kang, Kwang Woo Kim, So Young Kim, Su Jung Kim, Jun Seok Oh, Won Yong Han
  • Stable liquid pharmaceutical preparation
    Patent number: 11951207
    Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: April 9, 2024
    Assignee: Celltrion Inc.
    Inventors: Joon Won Lee, Won Yong Han, Su Jung Kim, Jun Seok Oh, So Young Kim, Su Hyeon Hong, Yeon Kyeong Shin
  • COMPOSITION COMPRISING OXIRACETAM FOR PREVENTING OR TREATING MUSCULAR DISEASE
    Publication number: 20240050406
    Abstract: The present invention relates to a novel use of oxiracetam, and a composition for improving, treating or preventing a muscle disease, comprising oxiracetam as an active ingredient. The composition of the present invention can prevent, treat or improve a muscle disease, and particularly, an improving, preventive or therapeutic effect thereof is confirmed in dexamethasone-treated animal model of muscular dystrophy, a muscular atrophy animal model, a senile sarcopenia animal model, a DMD animal model, a cachexia muscle disease cell model and an inflammatory muscle disease cell model. Therefore, it can be applied as a pharmaceutical composition or food composition for preventing or treating a muscle disease.
    Type: Application
    Filed: April 26, 2022
    Publication date: February 15, 2024
    Inventors: Bokyung KIM, Seung Hyo JUNG, Kyung-Jin LEE, Su Jung KIM
  • STABLE PHARMACEUTICAL FORMULATION, VIAL, CARTRIDGE, PRE-FILLED SYRINGE AND AUTO-INJECTOR COMPRISING THE SAME
    Publication number: 20230312734
    Abstract: The stable pharmaceutical formulation according to the present disclosure comprises (A) an antibody or antigen-binding fragment thereof that binds to an interleukin-6 receptor; (B) a surfactant; (C) stabilizers; and (D) a buffer. The stable pharmaceutical formulation according to the present disclosure has a low viscosity even when it contains an antibody, especially at a high concentration, and has excellent long-term storage stability based on excellent stability under accelerated and severe conditions, and may be administered intravenously or subcutaneously.
    Type: Application
    Filed: August 30, 2021
    Publication date: October 5, 2023
    Inventors: Ji Won Roh, Kwang Woo Kim, Su Jung Kim, Yeon Kyeong Shin, Won Yong Han, Jun Seok Oh, Jae Bin Lee
  • STABLE PHARMACEUTICAL PREPARATION
    Publication number: 20230312683
    Abstract: A stable pharmaceutical formulation according to the present disclosure contains: a recombinant fusion protein; a surfactant; a sugar or a derivative thereof; a buffer; and an isotonic agent. The stable pharmaceutical formulation according to the present disclosure has low viscosity while containing the recombinant fusion protein, may maintain excellent stability under long-term storage conditions, accelerated conditions and stress conditions, and may be administered intraocularly.
    Type: Application
    Filed: July 29, 2021
    Publication date: October 5, 2023
    Inventors: Su Jung Kim, Kwang Woo Kim, Ji Won Roh, Yeon Kyeong Shin, Jun Seok Oh, Jae Bin Lee, Won Yong Han
  • Stable liquid pharmaceutical preparation
    Patent number: 11730698
    Abstract: A stable liquid pharmaceutical formulation according to the present invention includes an antibody or antigen-binding fragment thereof, a surfactant, a sugar or a sugar derivative, a buffer, and a stabilizer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity not only when antibody content is low but also when antibody content is high, and exhibits superior long-term storage stability based on superior stability observed under accelerated conditions and harsh conditions.
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: August 22, 2023
    Assignee: CELLTRION INC.
    Inventors: So Young Kim, Yeon Kyeong Shin, Hye Young Kang, Kwang Woo Kim, Jun Seok Oh, Su Jung Kim, Joon Won Lee, Won Yong Han, Jae Bin Lee, Ji Won Roh, Ji Min Kwak
  • METHOD FOR PROVIDING ITEM INFORMATION AND AN APPARATUS FOR THE SAME
    Publication number: 20220292564
    Abstract: Provided is a method for providing item information of an electronic apparatus including at least one of identifying an item according to a first input of a user; identifying first review information created by selecting one from an answer set to a specific attribute of the item by purchasers and second review information on an answer determined based on a frequency of selection of the purchasers from the first review information; and providing a terminal of the user with a first page including information on or regarding the item, the first review information displayed in a first area, and the second review information displayed in a second area distinguished from the first area.
    Type: Application
    Filed: April 8, 2021
    Publication date: September 15, 2022
    Inventors: Su Jung Kim, Nae Jin Hyeon, Yeon Joo Ro
  • Magnetic shielding unit for wireless power transmission and wireless power transmission module including same
    Patent number: 11412644
    Abstract: Disclosed is a magnetic field shielding unit for wireless power transmission. The magnetic field shielding unit for wireless power transmission includes a magnetic shielding layer formed of ferrite fragments containing magnesium oxide (MgO) shredded to improve flexibility of the magnetic field shielding unit. The ferrite containing magnesium oxide has a real part (??) of the complex permeability of 650 or more at a frequency of 100 kHz. Accordingly, it is possible to prevent influence of a magnetic field on components of a mobile terminal device or a body of a user who uses the same, and to further increase the characteristics of the combined antennas even if the magnetic field shielding unit is combined with various kinds and purposes of antennas having various structures, shapes, sizes and intrinsic characteristics (inductance, resistivity, etc.).
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: August 9, 2022
    Assignee: Amotech Co., Ltd.
    Inventors: Woong Yong Lee, Kil Jae Jang, Seong Tae Kim, Su Jung Kim
  • Stable pharmaceutical formulation
    Patent number: 11236146
    Abstract: Disclosed is a stable pharmaceutical formulation, comprising a fusion protein in which the extracellular ligand-binding domain of a human p75 tumor necrosis factor receptor is fused to the Fc domain of human IgG and a succinate buffering agent, without comprising a stabilizer. The stable pharmaceutical formulation enables the long-term storage of the TNFR-Fc fusion protein formulation and can exhibit superior storage stability without the need for demanding storage conditions, and is a simple formulation because no stabilizer is comprised therein and is thus more economical than other stabilizer-comprising formulations.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: February 1, 2022
    Assignee: Celltrion Inc.
    Inventors: Joon Won Lee, Won Yong Han, Su Jung Kim, Jun Seok Oh, So Young Kim, Kwang Woo Kim, Yeon Kyeong Shin
  • STABLE LIQUID PHARMACEUTICAL FORMULATION OF ANTI-INFLUENZA VIRUS ANTIBODY
    Publication number: 20210347861
    Abstract: A stable liquid pharmaceutical preparation of an anti-influenza virus antibody and, more specifically, a stable liquid pharmaceutical preparation that comprises: (A) an anti-influenza virus antibody or a mixture of two or more different types of anti-influenza virus antibodies; (B) a surfactant; (C) a sugar or a sugar derivative; and (D) an amino acid. The stable liquid pharmaceutical preparation for an anti-influenza virus antibody disclosed herein has excellent storage stability at low temperature (5° C.), room temperature (25° C.), and high temperature (40° C.) and excellent long-term (12 months) storage stability, and may be administered intravenously, intramuscularly, transdermally, subcutaneously, intraperitoneally, topically, or in combinations thereof.
    Type: Application
    Filed: August 9, 2017
    Publication date: November 11, 2021
    Inventors: Joon Won Lee, Won Yong Han, Su Jung Kim, Jun Seok Oh, So Young Kim, Kwang Woo Kim, Yeon Kyeong Shin
  • Stable Liquid Pharmaceutical Preparation
    Publication number: 20210315813
    Abstract: A stable liquid pharmaceutical formulation according to the present invention includes an antibody or antigen-binding fragment thereof, a surfactant, a sugar or a sugar derivative, a buffer, and a stabilizer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity not only when antibody content is low but also when antibody content is high, and exhibits superior long-term storage stability based on superior stability observed under accelerated conditions and harsh conditions.
    Type: Application
    Filed: July 18, 2019
    Publication date: October 14, 2021
    Applicant: CELLTRION INC.
    Inventors: So Young Kim, Yeon Kyeong Shin, Hye Young Kang, Kwang Woo Kim, Jun Seok Oh, Su Jung Kim, Joon Won Lee, Won Yong Han, Jae Bin Lee, Ji Won Roh, Ji Min Kwak
  • STABLE LIQUID FORMULA
    Publication number: 20210205454
    Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.
    Type: Application
    Filed: March 16, 2021
    Publication date: July 8, 2021
    Applicant: CELLTRION INC.
    Inventors: Joon Won LEE, Yeon Kyeong SHIN, Hye Young KANG, Kwang Woo KIM, So Young KIM, Su Jung KIM, Jun Seok OH, Won Yong HAN
  • APPARATUS AND METHOD FOR CONSTRUCTING LIBRARY FOR DERIVING MATERIAL COMPOSITION
    Publication number: 20210166791
    Abstract: An apparatus for constructing a library for deriving a material composition using empirical result, which enables acceleration of research on the material-properties relationship. By applying the empirical results of the material composition, missing data of the material compositions can be statistically calculated by using supervised non-linear imputation techniques. The completed composition information of the materials is passed as an input of machine learning material-properties relationship prediction.
    Type: Application
    Filed: December 18, 2019
    Publication date: June 3, 2021
    Inventors: Seung Bum HONG, Eun Ae CHO, Jong Min YUK, Hye Ryung BYON, Yong Soo YANG, Pyuck Pa CHOI, Jong Hwa SHIN, Hyuck Mo LEE, CHI HAO LIOW, Seong Woo CHO, Gun PARK, Yong Ju LEE, Yoon Su SHIM, Moo Ny NA, Ho Sun JUN, Ki Hoon BANG, Myung Joon KIM, Chae Hwa JEONG, Seung Gu KIM, Chung Ik OH, Hong Jun KIM, Jae Gyu KIM, Ji Min OH, Ji Won YEOM, Seong Mun EOM, Hyoung Kyu KIM, Young Joon HAN, Dae Hee LEE, Ho Jun LEE, Jae Woon KIM, Jae Wook SHIN, Hyeon Muk KANG, Jae Yeol PARK, Han Beom JEONG, Jae Sang LEE, Joon Ha CHANG, Yo Han KIM, Su Jung KIM, Hyun Jeong OH, Arthur Baucour, Jae Wook HAN, Kyu Seon JANG, Hye Sung JO, Bo Ryung YOO, Hyeon Jin PARK, Min Gwan CHO, Jun Hyung PARK, Yea Eun KIM, Seok Hwan MIN, Jung Woo CHOI, Young Tae PARK, Doo Sun HONG
  • Stable liquid formula having an anti-TNFalpha antibody, acetate buffer and glycine
    Patent number: 10980881
    Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: April 20, 2021
    Assignee: CELLTRION INC.
    Inventors: Joon Won Lee, Yeon Kyeong Shin, Hye Young Kang, Kwang Woo Kim, So Young Kim, Su Jung Kim, Jun Seok Oh, Won Yong Han
  • STABLE LIQUID PHARMACEUTICAL PREPARATION
    Publication number: 20210000743
    Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.
    Type: Application
    Filed: June 28, 2017
    Publication date: January 7, 2021
    Inventors: Joon Won Lee, Won Yong Han, Su Jung Kim, Jun Seok Oh, So Young Kim, Su Hyeon Hong, Yeon Kyeong Shin